Which are the causes of Ewings sarcoma?

Ewing sarcoma is primarily caused by sporadic, non-inherited genetic mutations—specifically a chromosomal translocation—that occur after birth rather than being passed down from parents. While the exact trigger for these initial genetic errors remains unknown, research focuses on the fusion of the EWSR1 gene with members of the ETS family of transcription factors, which drives abnormal cell growth.

What causes Ewing sarcoma at a cellular level?

At the core of Ewing sarcoma development is a specific genetic mistake known as a somatic mutation. In the vast majority of cases (approximately 85%), a translocation occurs where parts of two chromosomes—chromosome 11 and chromosome 22—break and swap places. This creates a "fusion gene" called EWSR1-FLI1. Think of this fusion gene as a broken instruction manual inside a cell: instead of telling the cell to mature and stop dividing, the faulty manual forces the cell to stay in a primitive, rapidly multiplying state. This uncontrolled proliferation is the hallmark of Ewing sarcoma.

Is Ewing sarcoma an inherited condition?

It is important for families to know that Ewing sarcoma is almost never hereditary. The genetic translocations mentioned above happen randomly in a single cell during a person's development. Because these mutations are "somatic" (occurring in non-reproductive cells), they are not passed from parents to children. There is no evidence that lifestyle choices, diet, or environmental exposures during pregnancy cause the development of Ewing sarcoma. It is a biological event that occurs by chance, and there is nothing a parent could have done to prevent it.

What are the known risk factors for Ewing sarcoma?

While the underlying cause is a random genetic event, researchers have identified certain factors that correlate with the disease. Unlike many cancers, there are no well-established environmental "triggers" like smoking or radiation exposure linked to Ewing sarcoma. Current observations include:

• Age: The disease is most frequently diagnosed in adolescents and young adults, with a peak incidence between the ages of 10 and 20.


• Ethnicity: Ewing sarcoma occurs significantly more often in individuals of European descent compared to those of African or Asian descent.


• Gender: There is a slightly higher incidence rate in males compared to females.


• Prior Treatment: While rare, patients who have received intensive radiation or chemotherapy for other childhood cancers may have a slightly elevated risk of developing secondary malignancies, though this is not the primary cause for most cases.

Why is the exact etiology of Ewing sarcoma still under study?

While we understand the "what" (the EWSR1-FLI1 fusion), researchers are still working to understand the "why." Current research is investigating how these fusion proteins interact with the cell’s internal machinery to "reprogram" the cell’s identity. By mapping these pathways, scientists hope to develop targeted therapies that can "turn off" the fusion gene without harming healthy cells. Within the Ewing sarcoma community at DiseaseMaps.org, where 242 members share their journeys, these ongoing clinical trials represent a significant beacon of hope for more precise, less toxic treatment options.

Next steps

• Consult a pediatric or orthopedic oncologist who specializes specifically in bone and soft tissue sarcomas.


• Request genetic counseling if you have specific questions about family history, though keep in mind the sporadic nature of the disease.


• Join a support group or the DiseaseMaps.org community to connect with other families navigating Ewing sarcoma.


• Discuss potential clinical trial enrollment with your medical team to explore the latest advancements in targeted molecular therapy.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Ewing Sarcoma.


• Orphanet: Ewing Sarcoma (ORPHA:3119).


• OMIM (Online Mendelian Inheritance in Man): Ewing Sarcoma; EWS.


• National Cancer Institute (NCI): Ewing Sarcoma Treatment (PDQ®)–Patient Version.